Clinical trial
Personalizing Docetaxel Dosing in Advanced Prostate Cancer
NCT04823910 is registered in ClinicalTrials.gov with Physiomics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalizing Docetaxel Dosing in Advanced Prostate Cancer
- Lead sponsor
- Physiomics
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 6, 2021
- Completion date
- December 31, 2022
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer